Friday 28 February 2014

Author(s): Latha Jishnu

Testing the CL route

Testing the CL route

Roche’s Herceptin will be a test case for government and generics industry as India readies to issue compulsory licences for life-saving drugs

The NATCO CL fallout

The NATCO CL fallout

The compulsory licence granted to Natco may not be a trendsetter but it will shake up the pharmaceuticals market

A myriad gene worries

A myriad gene worries

Angelina Jolie’s dramatic disclosure has focused attention on gene patenting which has become a problematic legal question

Drug affordability test

Drug affordability test

Natco’s bid for a compulsory licence to manufacture a Bayer anti-cancer drug is a test of the law’s ‘reasonable price’ criterion  

Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.

  • Beautiful article. Very

    Beautiful article. Very informative. Thanks DTE. It surprises me everytime I read an article of DTE the range of issues it touches upon and how beautifully without using too much technical jargons explain the issues.

    Posted by: Anonymous | 12 months ago | Reply
Scroll To Top